SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Politics : Politics for Pros- moderated -- Ignore unavailable to you. Want to Upgrade?


To: skinowski who wrote (723032)8/7/2020 9:59:18 AM
From: Sdgla3 Recommendations

Recommended By
burlegoat
D. Long
garrettjax

  Read Replies (1) | Respond to of 793928
 
Hope we learn but doubt politics will change



To: skinowski who wrote (723032)8/7/2020 1:48:17 PM
From: i-node2 Recommendations

Recommended By
kech
pheilman_

  Read Replies (1) | Respond to of 793928
 
>> He tried to explain that the withdrawal of the Emergency Use Authorization was not meant to interfere with off label prescribing of HCQ. And technically, it didn’t - but in reality, it had a big negative impact.

I agree with you. When I first heard about the EUA I thought what the hell? But on reading about it, I didn't think it would affect outpatient's access. But the news media didn't distinguish, and you tell me, does a busy physician have time to sit around reading this stuff? I don't know. There are certainly no HCQ salesmen coming around to encourage you to use it.

At the same time, when asked about it, the FDA guy sort of dodged the question in an unhelpful way - "That's between you and your doctor." True, but not a strong endorsement.

I think I'm going to have an anger problem with this for a while ;)